| Literature DB >> 19228403 |
Xinkun Wang1, Asma Zaidi, Ranu Pal, Alexander S Garrett, Rogelio Braceras, Xue-wen Chen, Mary L Michaelis, Elias K Michaelis.
Abstract
BACKGROUND: Oxidative stress (OS) is an important factor in brain aging and neurodegenerative diseases. Certain neurons in different brain regions exhibit selective vulnerability to OS. Currently little is known about the underlying mechanisms of this selective neuronal vulnerability. The purpose of this study was to identify endogenous factors that predispose vulnerable neurons to OS by employing genomic and biochemical approaches.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19228403 PMCID: PMC2677396 DOI: 10.1186/1471-2202-10-12
Source DB: PubMed Journal: BMC Neurosci ISSN: 1471-2202 Impact factor: 3.288
Figure 1Effect of paraquat and of differential levels of oxygen tension on the viability of primary CbG and cerebral cortical (CTX) neurons. (A) Effects of paraquat on neuronal viability. Both types of neurons were exposed to the indicated concentrations of paraquat for 24 h at 37°C. Cell viability was determined by the calcein AM and PI labeling method. Data represent the mean (± SEM) of neuronal viability from 10 experiments. The P values from Student's t-test are shown for the indicated comparisons. (B, C) Survival of neurons across days in vitro (DIV) under different levels of oxygen (5% and 20%). Viability of neurons was measured by the MTT assay. The data represent the mean (± SEM) from 3 experiments. Statistically significant differences (t-test) are shown for the indicated comparisons.
Figure 2Selective vulnerability of hippocampal CA1 and CbG neurons as compared with CA3 and CTX neurons in organotypic brain slice cultures and in acute slice preparations. Both organotypic brain slice cultures and acute slice preparations were treated with paraquat (100 μM, 1 h). Cell survival was determined by PI labeling. Data represent the mean ± SEM. The number of experiments were n = 6 for (A) and n = 3 for (B). Statistically significant differences (t-test) are shown for the indicated comparisons.
Figure 3Protein levels of NADPH-cytochrome P450 reductase and for cellular oxidoreductases in CTX and CbG neurons. (A) Protein levels of NADPH-cytochrome P450 reductase in neurons. Immune labeling with anti-cytochrome P450 reductase antibodies was performed on proteins extracted from neurons cultured under conditions of 20% O2 tension. Results of densitometric measurements of the immuno-reactive band in each immunoblot are shown as the mean (± SEM) of 5 experiments. Statistically significant differences (t-test) are shown for the indicated comparisons. (B) Protein levels of SOD1, SOD2, and GPX1 in neurons. Immune labeling with anti-SOD1, anti-SOD2, and anti-GPX1 antibodies was performed on proteins extracted from neurons cultured as described in A. Results of densitometric measurements of the immuno-reactive bands in each immunoblot are shown as the mean (± SEM) of 3 experiments. Statistically significant differences (t-test) are shown for the indicated comparisons. (C) Effect of paraquat-induced OS on the protein levels of SOD1, SOD2, and GPX1 in neurons. Primary neurons in culture were exposed to the indicated concentrations of paraquat for 24 h at 37°C. Immune labeling with antibodies was performed as described in B. Results of densitometric measurements of the immuno-reactive bands in each immunoblot are shown as the mean (± SEM) of 3–5 experiments. Statistically significant differences (t-test) are shown for the indicated comparisons.
Figure 4LCM of neurons from the pyramidal cell layers of CA1 and CA3 of hippocampus, CbG cells of cerebellum, and layers IV-VI of cerebral cortex, and condition tree and Principal Components Analysis of microarray data from the captured neurons. (A) LCM capture of neurons from the four brain regions. The upper row shows the lightly stained populations of neurons in the respective brain sections, the middle row shows the image of the sections after neuronal capture by LCM, and the bottom row shows the captured neurons on the LCM cap. (B) Condition tree analysis of microarray data. Condition tree analysis was based on expression values of all probesets on the Affymetrix RAE230A GeneChip (color bar shown at right indicates relative gene expression levels). Pearson correlation was used as measurement of similarity. (C) PCA of microarray data. This analysis allowed for the visualization of the relationships among samples from the four brain regions.
Figure 5Identification of differentially expressed genes (orange colored) between the vulnerable (VUL) and resistant (RES) groups by volcano plot. The Y-axis displays the negative log (base 10) of P values from paired t-tests, while the X-axis shows the log (base 2) of the -fold differences between the two groups (VUL/RES). The blue line represents the P = 0.05 value, and the red lines correspond to fold differences of 1.5 and -1.5, respectively. Genes with paired t-test P < 0.05, and fold difference ≥1.5 or ≤-1.5, were identified as differentially expressed genes and are highlighted in orange.
Figure 6Comparison of transcriptomic profiles between the VUL and RES neurons based on biological functions associated with the differentially expressed genes identified in each neuronal group. The threshold line corresponds to the -log value for P = 0.05. Values of significance that is higher than threshold indicate greater numbers of genes, from either VUL or RES neurons, associated with the corresponding biological function. For example, although expression of genes related to the biological function of "Gene Expression" reached a value of significance above-threshold for both VUL and RES neurons, there were many more genes expressed in VUL neurons (54 in total) than the RES neurons (2), thus a higher -log P value for VUL than RES.
Gene Ontology (GO) terms significantly enriched with differentially expressed genes
| DNA repair (GO:0006281) | BP | 4.684 | 0.001 | |
| Response to DNA damage stimulus (GO:0006974) | BP | 4.488 | 0.002 | |
| Regulation of transcription (GO:0045449) | BP | 2.395 | 0.011 | |
| Intramolecular oxidoreductase activity (GO:0016860) | MF | 3.165 | 0.040 | |
| Calcium- and calmodulin-dependent protein kinase activity (GO:0004685) | MF | 5.475 | 0 | |
| Energy derivation by oxidation of organic compounds (GO:0015980) | BP | 2.839 | 0.004 | |
| Neurotransmitter transport (GO:0006836) | BP | 3.313 | 0.008 | |
| Main pathways of carbohydrate metabolism (GO:0006092) | BP | 2.739 | 0.010 | |
| Synaptic vesicle (GO:0008021) | CC | 2.96 | 0.012 | |
| Regulation of neurotransmitter secretion (GO:0046928) | BP | 3.902 | 0.022 | |
| Regulation of action potential (GO:0001508) | BP | 3.902 | 0.022 | |
| Regulation of signal transduction (GO:0009966) | BP | 2.858 | 0.025 | |
* BP – Biological Process; CC – Cellular Component; MF – Molecular Function
Biological pathways significantly enriched with differentially expressed genes
| For genes expressed at higher levels in neurons vulnerable to OS | |||
| mRNA processing reactome | 5.708 | 0 | |
| Pyrimidine metabolism | 3.921 | 0.008 | |
| Alanine and aspartate metabolism | 3.265 | 0.021 | |
| MAPK cascade | 6.016 | 0 | |
| Citrate (or TCA) cycle | 3.897 | 0.006 | |
| Regulation of actin cytoskeleton | 2.524 | 0.014 | |
| Prostaglandin synthesis regulation | 3.315 | 0.015 | |
| Wnt signaling | 2.882 | 0.020 | |
| Insulin signaling | 2.136 | 0.035 | |
| G protein signaling | 2.154 | 0.041 | |
Figure 7Validation of microarray data by real-time qPCR. Shown are the average ratios (± SEM, n = 3) of expression of the genes Mt1a, Nefl, Nfe2l2, and Tf, in VUL vs. RES neurons as measured by GeneChip and qPCR. The qPCR measurements are not significantly different from the GeneChip data (P values range: 0.199 – 0.896).
Figure 8Differential levels of ATP and the effect of paraquat on these levels in CTX and CbG neurons. Data represent the mean (± SEM) of ATP levels from 8 experiments. The P values for the indicated comparisons (t-test) are shown.
Currently known genes that were more highly expressed in resistant than vulnerable neurons in both the present and previous study [21]
| 1372953_at | neurocalcin delta | 7.90 | 3.79E-04 | |
| 1370058_at | neurofilament, light polypeptide | 3.28 | 9.53E-04 | |
| 1390358_at | calcium channel, voltage-dependent, alpha 2/delta 3 subunit | 2.91 | 0.019 | |
| 1368810_a_at | myelin basic protein | 2.33 | 0.011 | |
| 1373646_at | RAB15, member RAS onocogene family | 2.17 | 2.22E-03 | |
| 1371057_at | gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 | 2.14 | 0.019 | |
| 1368114_at | fibroblast growth factor 13 | 2.13 | 1.26E-03 | |
| 1368523_at | Ca2+-dependent secretion activator | 1.86 | 3.31E-03 | |
| 1386943_at | plasma membrane proteolipid | 1.59 | 0.025 | |
| 1368861_a_at | myelin-associated glycoprotein | 1.56 | 0.024 | |
| 1387961_at | opioid binding protein/cell adhesion molecule-like | 1.50 | 4.37E-04 | |
a,b – Calculations based on data from this study. Since the previous study [21] was a time-course study, no corresponding data were available.